Ligand validation:5SNA

GX4: cyclopropyl-[4-(4-fluorophenyl)piperazin-1-yl]methanone

GX4 is a Ligand Of Interest in 5SNA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5SNA_GX4_A_501	13%	26%	0.266	0.807	1.5	1.49	3	5	2	0	100%	0.48
5SO1_GX4_A_502	20%	19%	0.188	0.79	2.01	1.43	6	3	0	0	100%	1
5RAH_GX4_A_1801	68%	19%	0.129	0.939	1.98	1.48	4	4	0	0	100%	0.82
5S4U_GX4_B_505	39%	43%	0.226	0.934	1.15	1.08	1	3	1	0	100%	1
5R4Y_GX4_A_1201	38%	17%	0.204	0.906	2.66	0.96	6	1	0	0	100%	1
5RKO_GX4_A_1501	6%	30%	0.272	0.706	1.61	1.21	5	5	0	0	100%	0.49

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.